We are live on ! Find out more
RE

RBC Europe Portfolio holdings

AUM $2.08B
1-Year Est. Return 12.2%
This Fund
S&P 500
This Quarter Est. Return
-12.51%
1 Year Est. Return
-12.2%
3 Year Est. Return
+59.81%
5 Year Est. Return
+127.03%
10 Year Est. Return
AUM
$767M
AUM Growth
-$135M
Cap. Flow
-$5.63M
Cap. Flow %
-0.73%
Top 10 Hldgs %
44.3%
Holding
1,179
New
45
Increased
120
Reduced
162
Closed
82

Top Buys

Rank Stock Value
1
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$5.77M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$2.96M
3
NKE icon
Nike
NKE
+$1.53M
4
V icon
Visa
V
+$1.36M
5
MSFT icon
Microsoft
MSFT
+$1.29M

Sector Composition

Rank Sector Weight
1 Financials 23.44%
2 Consumer Discretionary 16.4%
3 Technology 15.93%
4 Communication Services 11.81%
5 Healthcare 10.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RYN icon
1001
Rayonier
RYN
$6.06B
$2.02K ﹤0.01%
80
VXZ
1002
DELISTED
iPath S&P 500 VIX Mid-Term Futures ETN due 1/30/2019
VXZ
$2K ﹤0.01%
90
AKBA icon
1003
Akebia Therapeutics
AKBA
$243M
$1.96K ﹤0.01%
+355
New +$2.78K
NAK
1004
Northern Dynasty Minerals
NAK
$944M
$1.94K ﹤0.01%
3,400
NOK icon
1005
Nokia
NOK
$57.2B
$1.92K ﹤0.01%
330
PRLB icon
1006
Protolabs
PRLB
$1.91B
$1.92K ﹤0.01%
17
RDC
1007
DELISTED
Rowan Companies Plc
RDC
$1.76K ﹤0.01%
210
SER icon
1008
Serina Therapeutics
SER
$62.5M
$1.7K ﹤0.01%
+16
New +$2.03K
UBX
1009
DELISTED
Unity Biotechnology
UBX
$1.63K ﹤0.01%
10
LTBR icon
1010
Lightbridge
LTBR
$283M
$1.56K ﹤0.01%
239
RMR icon
1011
The RMR Group
RMR
$332M
$1.49K ﹤0.01%
28
ACH
1012
Accendra Health
ACH
$93.1M
$1.46K ﹤0.01%
231
NBRV
1013
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$1.46K ﹤0.01%
4
LKSD
1014
DELISTED
LSC Communications, Inc.
LKSD
$1.4K ﹤0.01%
200
BPY
1015
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
$1.35K ﹤0.01%
84
-117
-58% -$2.14K
DNN icon
1016
Denison Mines
DNN
$3.07B
$1.35K ﹤0.01%
2,906
VXRT
1017
DELISTED
Vaxart
VXRT
$1.32K ﹤0.01%
701
BHF icon
1018
Brighthouse Financial
BHF
$3.05B
$1.31K ﹤0.01%
43
SRRA
1019
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.29K ﹤0.01%
24
PBJ icon
1020
Invesco Food & Beverage ETF
PBJ
$91.5M
$1.25K ﹤0.01%
42
REGN icon
1021
Regeneron Pharmaceuticals
REGN
$81.8B
$1.12K ﹤0.01%
3
PBR icon
1022
Petrobras
PBR
$119B
$1.09K ﹤0.01%
84
KSS icon
1023
Kohl's
KSS
$1.98B
$1.06K ﹤0.01%
16
VSLR
1024
DELISTED
VIVINT SOLAR, INC.
VSLR
$1.01K ﹤0.01%
+265
New +$1.37K
LL
1025
DELISTED
LL Flooring Holdings, Inc.
LL
$952 ﹤0.01%
100

Similar funds

RBC Europe's Q4 2018 Portfolio in Review

As of Q4 2018, RBC Europe held 1,179 positions worth $767M, down 15% from $901M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

RBC Europe's Q4 2018 filing shows 45 new, 120 increased, 162 reduced and 82 closed positions. Its largest new stake was Cigna: 3,637 shares worth $691K. The largest sale was Meta Platforms (Facebook), an estimated $4.72M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Technology.

  • RBC Europe's largest Q4 2018 buy was Cigna: 3,637 shares worth $691K.
  • RBC Europe added most to Berkshire Hathaway Class B in Q4 2018, an estimated $5.77M increase.
  • RBC Europe's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $4.72M.
  • RBC Europe fully exited Mimecast Limited in Q4 2018, selling an estimated $4.19M.
  • RBC Europe's ten largest holdings make up 44% of its $767M portfolio in Q4 2018.
  • RBC Europe opened 45 new positions and closed 82 in Q4 2018.
  • RBC Europe's portfolio value fell 15% quarter-over-quarter to $767M.

Based on RBC Europe's 13F filing for Q4 2018, filed 9 Nov 2023.